Study of a new heart device for atrial fibrillation patients
Part of Heart & circulation clinical trials.
This trial tests a new device called LAmbre™ II that closes off a part of the heart called the left atrial appendage to help prevent strokes in people with atrial fibrillation who cannot take blood thinners.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have atrial fibrillation that comes and goes, stays all the time, or is long-lasting, but not caused by heart valve problems.
- Your stroke risk score is 2 or higher for men or 3 or higher for women.
- You have a reason to avoid blood thinners, like side effects or other risks.
- You agree to take required medicines and come for follow-up visits after the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a device that is placed in a small pouch of the heart (left atrial appendage) to help prevent strokes in people with atrial fibrillation who cannot take blood thinners safely. The device is already used in some patients; this trial watches how well the heart heals around it over time.
This trial tests a device that closes off a small pouch in the heart where blood clots can form in people with atrial fibrillation. This may help reduce the risk of stroke without needing long-term blood thinners.
This study compares two devices (LAmbre and AMPLATZER Amulet) that are placed in the heart to prevent strokes in people with atrial fibrillation who cannot take blood thinners. If you join, you will be randomly assigned to get one of the two devices.
This study is testing a device called LAMBRE that is used to close a small pocket in the heart (the left atrial appendage). The goal is to see how well it works in everyday medical practice for people who need this closure procedure.
This study compares two similar devices that close off a small pocket in the heart to reduce stroke risk in people with atrial fibrillation who cannot take blood thinners safely. The goal is to see which device works better and is safer.
This trial tests a new device called ENDOMATIC SEPIOLA that closes a small pouch in your heart (the left atrial appendage) to lower your stroke risk. It is a non-surgical option for people with atrial fibrillation who cannot take blood thinners.
Hear when a new Non-valvular Atrial Fibrillation (NVAF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.